C-Reactive Protein Testing Market Insights, Competitive Landscape, and Market Forecast

Description

The global C-Reactive Protein (CRP) Testing Market is experiencing steady growth as the demand for precise diagnostic tools rises across healthcare sectors. CRP testing, which measures levels of C-reactive protein-a key indicator of inflammation in the body-has become essential for detecting infections, cardiovascular diseases, and autoimmune disorders. The market is projected to grow from USD 5.5 billion in 2026 to USD 6.2 billion by 2033, registering a moderate compound annual growth rate (CAGR) of 1.70% over the forecast period. This growth highlights the increasing importance of early diagnosis, disease management, and preventive healthcare practices worldwide.

Market Insights

CRP testing is widely used in hospitals, clinical laboratories, and point-of-care (POC) settings. The market is driven by the growing need for reliable and rapid diagnostic tools to monitor inflammatory conditions. Innovations such as high-sensitivity CRP (hs-CRP) tests, chemiluminescence immunoassays (CLIA), and automated laboratory systems have improved test accuracy, efficiency, and turnaround time.

The adoption of POC testing has also expanded, particularly in regions where rapid diagnostics are critical for patient management. Portable CRP analyzers and easy-to-use test kits allow healthcare providers to deliver timely results outside conventional laboratory environments, improving clinical decision-making. Increasing awareness among patients and healthcare providers about preventive care further supports market expansion.

Market Drivers

Several factors are fueling growth in the CRP testing market:

1. Increasing Prevalence of Chronic and Infectious Diseases: Cardiovascular disorders, sepsis, and autoimmune conditions are major drivers for CRP testing, as these illnesses require regular monitoring of inflammatory biomarkers.
2. Technological Advancements: Development of high-sensitivity assays, automated analyzers, and integrated diagnostic platforms has enhanced testing accuracy, efficiency, and scalability.
3. Focus on Preventive Healthcare: Growing emphasis on early detection and patient monitoring encourages the routine use of CRP testing in both outpatient and inpatient care.
4. Expansion of Point-of-Care Testing: The convenience and speed of POC diagnostics have increased the adoption of CRP tests in clinics, remote healthcare centers, and emergency care units.
5. Supportive Policies and Funding: Government initiatives aimed at improving diagnostic infrastructure and healthcare services are positively impacting market growth.

Business Opportunity

The CRP testing market offers lucrative opportunities for manufacturers, diagnostic service providers, and technology developers. High-demand areas include hs-CRP testing for cardiovascular risk assessment, automated instruments for clinical laboratories, and compact POC devices for remote or resource-limited regions.

Strategic partnerships between diagnostic companies and healthcare providers can further drive adoption of advanced CRP testing solutions. Emerging economies represent significant growth potential due to expanding hospital networks, increasing healthcare awareness, and rising disposable income. Companies introducing cost-effective, reliable, and rapid diagnostic tools are well-positioned to capture this growing market segment.

Regional Analysis

The CRP testing market shows significant regional variations:

North America: Dominates due to advanced healthcare infrastructure, high prevalence of chronic diseases, and rapid adoption of innovative diagnostics.
Europe: Growth supported by well-established laboratory networks, robust healthcare policies, and a strong focus on preventive healthcare.
Asia Pacific: Expanding rapidly, driven by increasing healthcare access, growing awareness of infectious and cardiovascular diseases, and rising adoption of POC testing.
Latin America: Moderate growth influenced by improving diagnostic infrastructure and government initiatives to enhance healthcare services.
Middle East & Africa: Steady growth fueled by healthcare infrastructure development, increasing hospital networks, and growing emphasis on early detection of diseases.

Key Players

The CRP testing market is competitive, with several global leaders contributing to technological innovations and market expansion. Key players include:

Abbott Laboratories
Roche Diagnostics
Siemens Healthineers
bioMerieux
Thermo Fisher Scientific
Danaher Corporation (Beckman Coulter & Leica Biosystems)
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
Horiba, Ltd.
Sysmex Corporation
Olympus Corporation
F. Hoffmann-La Roche Ltd. (CRP reagents & platforms)
Tosoh Corporation
Siemens Healthcare Diagnostics
QuidelOrtho Corporation

These companies focus on continuous research and development, strategic collaborations, and launch of innovative products to strengthen market positioning. Investments in automated instruments, high-sensitivity assays, and portable POC devices are expected to create a competitive edge.

Market Segmentation

The CRP testing market can be segmented based on product, assay type, detection range, setting, end user, and region. This segmentation allows industry stakeholders to identify growth opportunities and optimize market strategies.

By Product:

Reagents & Kits
Instruments

By Assay Type:

Chemiluminescence Immunoassay (CLIA)
Enzyme-Linked Immunosorbent Assay (ELISA)
Immunoturbidimetric Assay
Others

By Detection Range:

Conventional CRP
hs-CRP

By Setting:

Laboratory Testing
Point-of-Care (POC) Testing

By End User:

Hospitals & Clinics
Diagnostic Laboratories
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global C-Reactive Protein Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors

3. Global C-Reactive Protein Testing Market Outlook, 2020 - 2033

3.1. Global C-Reactive Protein Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 3.1.1. Reagents & Kits
- 3.1.2. Instruments
3.2. Global C-Reactive Protein Testing Market Outlook, by Assay Type, Value (US$ Bn), 2020-2033
- 3.2.1. Chemiluminescence Immunoassay (CLIA)
- 3.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 3.2.3. Immunoturbidimetric Assay
- 3.2.4. Others
3.3. Global C-Reactive Protein Testing Market Outlook, by Detection Range, Value (US$ Bn), 2020-2033
- 3.3.1. Conventional CRP
- 3.3.2. hs-CRP
3.4. Global C-Reactive Protein Testing Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 3.4.1. Laboratory Testing
- 3.4.2. Point-of-Care (POC) Testing
3.5. Global C-Reactive Protein Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.5.1. Hospitals & Clinics
- 3.5.2. Diagnostic Laboratories
- 3.5.3. Others
3.6. Global C-Reactive Protein Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.6.1. North America
- 3.6.2. Europe
- 3.6.3. Asia Pacific
- 3.6.4. Latin America
- 3.6.5. Middle East & Africa

4. North America C-Reactive Protein Testing Market Outlook, 2020 - 2033

4.1. North America C-Reactive Protein Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 4.1.1. Reagents & Kits
- 4.1.2. Instruments
4.2. North America C-Reactive Protein Testing Market Outlook, by Assay Type, Value (US$ Bn), 2020-2033
- 4.2.1. Chemiluminescence Immunoassay (CLIA)
- 4.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 4.2.3. Immunoturbidimetric Assay
- 4.2.4. Others
4.3. North America C-Reactive Protein Testing Market Outlook, by Detection Range, Value (US$ Bn), 2020-2033
- 4.3.1. Conventional CRP
- 4.3.2. hs-CRP
4.4. North America C-Reactive Protein Testing Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 4.4.1. Laboratory Testing
- 4.4.2. Point-of-Care (POC) Testing
4.5. North America C-Reactive Protein Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.5.1. Hospitals & Clinics
- 4.5.2. Diagnostic Laboratories
- 4.5.3. Others
4.6. North America C-Reactive Protein Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.6.1. U.S. C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 4.6.2. U.S. C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 4.6.3. U.S. C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 4.6.4. U.S. C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 4.6.5. U.S. C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 4.6.6. Canada C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 4.6.7. Canada C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 4.6.8. Canada C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 4.6.9. Canada C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 4.6.10. Canada C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
4.7. BPS Analysis/Market Attractiveness Analysis

5. Europe C-Reactive Protein Testing Market Outlook, 2020 - 2033

5.1. Europe C-Reactive Protein Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 5.1.1. Reagents & Kits
- 5.1.2. Instruments
5.2. Europe C-Reactive Protein Testing Market Outlook, by Assay Type, Value (US$ Bn), 2020-2033
- 5.2.1. Chemiluminescence Immunoassay (CLIA)
- 5.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 5.2.3. Immunoturbidimetric Assay
- 5.2.4. Others
5.3. Europe C-Reactive Protein Testing Market Outlook, by Detection Range, Value (US$ Bn), 2020-2033
- 5.3.1. Conventional CRP
- 5.3.2. hs-CRP
5.4. Europe C-Reactive Protein Testing Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 5.4.1. Laboratory Testing
- 5.4.2. Point-of-Care (POC) Testing
5.5. Europe C-Reactive Protein Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.5.1. Hospitals & Clinics
- 5.5.2. Diagnostic Laboratories
- 5.5.3. Others
5.6. Europe C-Reactive Protein Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.6.1. Germany C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 5.6.2. Germany C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 5.6.3. Germany C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 5.6.4. Germany C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 5.6.5. Germany C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 5.6.6. Italy C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 5.6.7. Italy C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 5.6.8. Italy C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 5.6.9. Italy C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 5.6.10. Italy C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 5.6.11. France C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 5.6.12. France C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 5.6.13. France C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 5.6.14. France C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 5.6.15. France C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 5.6.16. U.K. C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 5.6.17. U.K. C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 5.6.18. U.K. C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 5.6.19. U.K. C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 5.6.20. U.K. C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 5.6.21. Spain C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 5.6.22. Spain C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 5.6.23. Spain C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 5.6.24. Spain C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 5.6.25. Spain C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 5.6.26. Russia C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 5.6.27. Russia C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 5.6.28. Russia C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 5.6.29. Russia C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 5.6.30. Russia C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 5.6.31. Rest of Europe C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 5.6.32. Rest of Europe C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 5.6.33. Rest of Europe C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 5.6.34. Rest of Europe C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 5.6.35. Rest of Europe C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
5.7. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific C-Reactive Protein Testing Market Outlook, 2020 - 2033

6.1. Asia Pacific C-Reactive Protein Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 6.1.1. Reagents & Kits
- 6.1.2. Instruments
6.2. Asia Pacific C-Reactive Protein Testing Market Outlook, by Assay Type, Value (US$ Bn), 2020-2033
- 6.2.1. Chemiluminescence Immunoassay (CLIA)
- 6.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 6.2.3. Immunoturbidimetric Assay
- 6.2.4. Others
6.3. Asia Pacific C-Reactive Protein Testing Market Outlook, by Detection Range, Value (US$ Bn), 2020-2033
- 6.3.1. Conventional CRP
- 6.3.2. hs-CRP
6.4. Asia Pacific C-Reactive Protein Testing Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 6.4.1. Laboratory Testing
- 6.4.2. Point-of-Care (POC) Testing
6.5. Asia Pacific C-Reactive Protein Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.5.1. Hospitals & Clinics
- 6.5.2. Diagnostic Laboratories
- 6.5.3. Others
6.6. Asia Pacific C-Reactive Protein Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.6.1. China C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 6.6.2. China C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 6.6.3. China C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 6.6.4. China C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 6.6.5. China C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 6.6.6. Japan C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 6.6.7. Japan C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 6.6.8. Japan C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 6.6.9. Japan C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 6.6.10. Japan C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 6.6.11. South Korea C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 6.6.12. South Korea C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 6.6.13. South Korea C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 6.6.14. South Korea C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 6.6.15. South Korea C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 6.6.16. India C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 6.6.17. India C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 6.6.18. India C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 6.6.19. India C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 6.6.20. India C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 6.6.21. Southeast Asia C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 6.6.22. Southeast Asia C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 6.6.23. Southeast Asia C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 6.6.24. Southeast Asia C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 6.6.25. Southeast Asia C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 6.6.26. Rest of SAO C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 6.6.27. Rest of SAO C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 6.6.28. Rest of SAO C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 6.6.29. Rest of SAO C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 6.6.30. Rest of SAO C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
6.7. BPS Analysis/Market Attractiveness Analysis

7. Latin America C-Reactive Protein Testing Market Outlook, 2020 - 2033

7.1. Latin America C-Reactive Protein Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 7.1.1. Reagents & Kits
- 7.1.2. Instruments
7.2. Latin America C-Reactive Protein Testing Market Outlook, by Assay Type, Value (US$ Bn), 2020-2033
- 7.2.1. Chemiluminescence Immunoassay (CLIA)
- 7.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 7.2.3. Immunoturbidimetric Assay
- 7.2.4. Others
7.3. Latin America C-Reactive Protein Testing Market Outlook, by Detection Range, Value (US$ Bn), 2020-2033
- 7.3.1. Conventional CRP
- 7.3.2. hs-CRP
7.4. Latin America C-Reactive Protein Testing Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 7.4.1. Laboratory Testing
- 7.4.2. Point-of-Care (POC) Testing
7.5. Latin America C-Reactive Protein Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.5.1. Hospitals & Clinics
- 7.5.2. Diagnostic Laboratories
- 7.5.3. Others
7.6. Latin America C-Reactive Protein Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.6.1. Brazil C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 7.6.2. Brazil C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 7.6.3. Brazil C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 7.6.4. Brazil C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 7.6.5. Brazil C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 7.6.6. Mexico C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 7.6.7. Mexico C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 7.6.8. Mexico C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 7.6.9. Mexico C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 7.6.10. Mexico C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 7.6.11. Argentina C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 7.6.12. Argentina C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 7.6.13. Argentina C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 7.6.14. Argentina C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 7.6.15. Argentina C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 7.6.16. Rest of LATAM C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 7.6.17. Rest of LATAM C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 7.6.18. Rest of LATAM C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 7.6.19. Rest of LATAM C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 7.6.20. Rest of LATAM C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
7.7. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa C-Reactive Protein Testing Market Outlook, 2020 - 2033

8.1. Middle East & Africa C-Reactive Protein Testing Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 8.1.1. Reagents & Kits
- 8.1.2. Instruments
8.2. Middle East & Africa C-Reactive Protein Testing Market Outlook, by Assay Type, Value (US$ Bn), 2020-2033
- 8.2.1. Chemiluminescence Immunoassay (CLIA)
- 8.2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
- 8.2.3. Immunoturbidimetric Assay
- 8.2.4. Others
8.3. Middle East & Africa C-Reactive Protein Testing Market Outlook, by Detection Range, Value (US$ Bn), 2020-2033
- 8.3.1. Conventional CRP
- 8.3.2. hs-CRP
8.4. Middle East & Africa C-Reactive Protein Testing Market Outlook, by Setting, Value (US$ Bn), 2020-2033
- 8.4.1. Laboratory Testing
- 8.4.2. Point-of-Care (POC) Testing
8.5. Middle East & Africa C-Reactive Protein Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.5.1. Hospitals & Clinics
- 8.5.2. Diagnostic Laboratories
- 8.5.3. Others
8.6. Middle East & Africa C-Reactive Protein Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.6.1. GCC C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 8.6.2. GCC C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 8.6.3. GCC C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 8.6.4. GCC C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 8.6.5. GCC C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 8.6.6. South Africa C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 8.6.7. South Africa C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 8.6.8. South Africa C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 8.6.9. South Africa C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 8.6.10. South Africa C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 8.6.11. Egypt C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 8.6.12. Egypt C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 8.6.13. Egypt C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 8.6.14. Egypt C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 8.6.15. Egypt C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 8.6.16. Nigeria C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 8.6.17. Nigeria C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 8.6.18. Nigeria C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 8.6.19. Nigeria C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 8.6.20. Nigeria C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
- 8.6.21. Rest of Middle East C-Reactive Protein Testing Market Outlook, by Product, 2020-2033
- 8.6.22. Rest of Middle East C-Reactive Protein Testing Market Outlook, by Assay Type, 2020-2033
- 8.6.23. Rest of Middle East C-Reactive Protein Testing Market Outlook, by Detection Range, 2020-2033
- 8.6.24. Rest of Middle East C-Reactive Protein Testing Market Outlook, by Setting, 2020-2033
- 8.6.25. Rest of Middle East C-Reactive Protein Testing Market Outlook, by End User, 2020-2033
8.7. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Abbott Laboratories
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. Roche Diagnostics
- 9.4.3. Siemens Healthineers
- 9.4.4. bioMerieux
- 9.4.5. Thermo Fisher Scientific
- 9.4.6. Danaher Corporation (Beckman Coulter & Leica Biosystems)
- 9.4.7. Becton, Dickinson and Company (BD)
- 9.4.8. Bio-Rad Laboratories, Inc.
- 9.4.9. Horiba, Ltd.
- 9.4.10. Sysmex Corporation

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

C-Reactive Protein Testing Market Insights, Competitive Landscape, and Market Forecast - 2033